Esther Hong
Stock Analyst at Loop Capital
(n/a)
# 4,703
Out of 5,134 analysts
15
Total ratings
9.09%
Success rate
-38.48%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Hong
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ATAI AtaiBeckley | Initiates: Buy | $18 | $3.57 | +404.20% | 2 | Nov 1, 2022 | |
| ACAD ACADIA Pharmaceuticals | Initiates: Hold | $17 | $22.03 | -22.83% | 2 | Nov 1, 2022 | |
| CMPS COMPASS Pathways | Initiates: Buy | $34 | $5.81 | +485.20% | 1 | Nov 1, 2022 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $95 | $181.21 | -47.57% | 2 | Nov 1, 2022 | |
| SPRO Spero Therapeutics | Downgrades: Hold | $2 | $2.39 | -16.32% | 2 | May 20, 2022 | |
| APRE Aprea Therapeutics | Downgrades: Hold | n/a | $0.61 | - | 2 | Aug 16, 2021 | |
| ALDX Aldeyra Therapeutics | Initiates: Buy | $32 | $5.28 | +506.06% | 4 | Dec 16, 2020 |
AtaiBeckley
Nov 1, 2022
Initiates: Buy
Price Target: $18
Current: $3.57
Upside: +404.20%
ACADIA Pharmaceuticals
Nov 1, 2022
Initiates: Hold
Price Target: $17
Current: $22.03
Upside: -22.83%
COMPASS Pathways
Nov 1, 2022
Initiates: Buy
Price Target: $34
Current: $5.81
Upside: +485.20%
Axsome Therapeutics
Nov 1, 2022
Initiates: Buy
Price Target: $95
Current: $181.21
Upside: -47.57%
Spero Therapeutics
May 20, 2022
Downgrades: Hold
Price Target: $2
Current: $2.39
Upside: -16.32%
Aprea Therapeutics
Aug 16, 2021
Downgrades: Hold
Price Target: n/a
Current: $0.61
Upside: -
Aldeyra Therapeutics
Dec 16, 2020
Initiates: Buy
Price Target: $32
Current: $5.28
Upside: +506.06%